Form 4: Immunome Executive Sells Shares
Insider Transaction (Form 4)
Kinney Horn, CHIEF BUSINESS OFFICER of Immunome Inc., sold 90,616 shares of common stock on August 4, 2026 for $25.09 per share.
Summary
- Option exercise/conversion: acquired 50,366 Common Stock at $12.92 ($650,729) on August 4, 2026; holds 50,366 after (Direct).
- Option exercise/conversion: acquired 40,250 Common Stock at $10.60 ($426,650) on August 4, 2026; holds 90,616 after (Direct).
- Open-market sale: disposed of 90,616 Common Stock at $25.09 ($2,273,555) on August 4, 2026 (Direct).
- Option exercise/conversion: disposed of 50,366 Employee Stock Option (right to buy) on August 4, 2026; holds 78,542 after (Direct).
- Option exercise/conversion: disposed of 40,250 Employee Stock Option (right to buy) on August 4, 2026; holds 120,750 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,273,555 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Kinney Horn — Officer (CHIEF BUSINESS OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Option exercise/conversion | Common Stock | 50,366 | $13 | $650.7K | 50,366 |
| 2026-08-04 | Option exercise/conversion | Common Stock | 40,250 | $11 | $426.6K | 90,616 |
| 2026-08-04 | Open-market sale | Common Stock | 90,616 | $25 | $2.3M | 0 |
| 2026-08-04 | Option exercise/conversion | Employee Stock Option (right to buy) | 50,366 | — | — | 78,542 |
| 2026-08-04 | Option exercise/conversion | Employee Stock Option (right to buy) | 40,250 | — | — | 120,750 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Option exercise/conversion (50,366 shares) |
| 2026-08-04 | Option exercise/conversion (40,250 shares) |
| 2026-08-04 | Open-market sale (90,616 shares) |
| 2026-08-04 | Option exercise/conversion (50,366 shares) |
| 2026-08-04 | Option exercise/conversion (40,250 shares) |
Keywords
insider transaction, Form 4, IMNM, Immunome Inc., bearish, Kinney Horn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.